beta

ELGX

Endologix, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.

Market Cap: 4.22 Million

Primary Exchange: NASDAQ

Website: http://www.endologix.com

Shares Outstanding: 19.2 Million

Float: 16.6 Million

Dividend: (%)

Beta: 0.7885182864870561

Sector: Health Technology

Industry: Medical Specialties

Ethical Flags

Longest drawdown: 1743 trading days

From: 2013-12-02 To: 2020-07-15

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud